Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900022904Phase 4Not yet recruiting
Phase 4, open-label trial of sertraline in obsessive compulsive disorder (OCD) (2 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoints: Yale-Brown Obsessive-Compulsive Scale, Chinese Version of Obsessive Belief Questionnaire-44 and 1 more. Planned start May 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900022904.